Alpha Pro Tech (APT) Competitors $4.84 +0.22 (+4.76%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$4.86 +0.02 (+0.41%) As of 08/22/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock APT vs. MGRM, CV, BSGM, TLSI, ELMD, LNSR, MBOT, PDEX, LAKE, and AVRShould you be buying Alpha Pro Tech stock or one of its competitors? The main competitors of Alpha Pro Tech include Monogram Orthopaedics (MGRM), CapsoVision (CV), Biosig Technologies (BSGM), TriSalus Life Sciences (TLSI), Electromed (ELMD), LENSAR (LNSR), Microbot Medical (MBOT), Pro-Dex (PDEX), Lakeland Industries (LAKE), and Anteris Technologies Global (AVR). These companies are all part of the "medical equipment" industry. Alpha Pro Tech vs. Its Competitors Monogram Orthopaedics CapsoVision Biosig Technologies TriSalus Life Sciences Electromed LENSAR Microbot Medical Pro-Dex Lakeland Industries Anteris Technologies Global Alpha Pro Tech (NYSE:APT) and Monogram Orthopaedics (NASDAQ:MGRM) are both small-cap medical equipment companies, but which is the better stock? We will compare the two companies based on the strength of their dividends, institutional ownership, earnings, media sentiment, profitability, analyst recommendations, risk and valuation. Does the media prefer APT or MGRM? In the previous week, Monogram Orthopaedics had 14 more articles in the media than Alpha Pro Tech. MarketBeat recorded 14 mentions for Monogram Orthopaedics and 0 mentions for Alpha Pro Tech. Monogram Orthopaedics' average media sentiment score of 0.41 beat Alpha Pro Tech's score of 0.00 indicating that Monogram Orthopaedics is being referred to more favorably in the news media. Company Overall Sentiment Alpha Pro Tech Neutral Monogram Orthopaedics Neutral Is APT or MGRM more profitable? Alpha Pro Tech has a net margin of 6.99% compared to Monogram Orthopaedics' net margin of 0.00%. Alpha Pro Tech's return on equity of 6.70% beat Monogram Orthopaedics' return on equity.Company Net Margins Return on Equity Return on Assets Alpha Pro Tech6.99% 6.70% 5.76% Monogram Orthopaedics N/A -126.82%-96.87% Do institutionals and insiders believe in APT or MGRM? 22.7% of Alpha Pro Tech shares are owned by institutional investors. Comparatively, 0.5% of Monogram Orthopaedics shares are owned by institutional investors. 15.0% of Alpha Pro Tech shares are owned by company insiders. Comparatively, 28.1% of Monogram Orthopaedics shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term. Which has stronger earnings & valuation, APT or MGRM? Alpha Pro Tech has higher revenue and earnings than Monogram Orthopaedics. Monogram Orthopaedics is trading at a lower price-to-earnings ratio than Alpha Pro Tech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Pro Tech$58.56M0.87$4.19M$0.3414.24Monogram Orthopaedics$370K598.47-$16.33M-$0.50-10.90 Which has more volatility and risk, APT or MGRM? Alpha Pro Tech has a beta of 0.24, indicating that its share price is 76% less volatile than the S&P 500. Comparatively, Monogram Orthopaedics has a beta of 0.69, indicating that its share price is 31% less volatile than the S&P 500. Do analysts recommend APT or MGRM? Monogram Orthopaedics has a consensus target price of $5.40, indicating a potential downside of 0.92%. Given Monogram Orthopaedics' stronger consensus rating and higher possible upside, analysts plainly believe Monogram Orthopaedics is more favorable than Alpha Pro Tech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Pro Tech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Monogram Orthopaedics 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryMonogram Orthopaedics beats Alpha Pro Tech on 9 of the 17 factors compared between the two stocks. Get Alpha Pro Tech News Delivered to You Automatically Sign up to receive the latest news and ratings for APT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding APT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart APT vs. The Competition Export to ExcelMetricAlpha Pro TechSurgical appliances & supplies IndustryIndustrials SectorNYSE ExchangeMarket Cap$50.69M$26.67M$7.74B$21.29BDividend YieldN/AN/A4.55%3.52%P/E Ratio13.0813.0826.1229.06Price / Sales0.872.0999.7555.22Price / Cash12.8012.8027.7918.24Price / Book0.912.134.404.70Net Income$4.19M-$5.31M$796.90M$992.19M7 Day Performance4.99%0.18%0.58%2.37%1 Month Performance1.47%0.94%0.48%2.18%1 Year Performance-23.90%-21.97%26.79%10.76% Alpha Pro Tech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)APTAlpha Pro TechN/A$4.84+4.8%N/A-23.9%$50.69M$58.56M13.08120Short Interest ↑MGRMMonogram Orthopaedics1.779 of 5 stars$5.33+0.1%$5.40+1.4%+58.4%$189.87M$370K-10.6428Trending NewsEarnings ReportShort Interest ↓Analyst RevisionCVCapsoVisionN/A$3.90-2.5%$5.50+41.0%N/A$180.74M$12.52M0.0090Gap DownBSGMBiosig Technologies2.0642 of 5 stars$5.29-3.6%$10.00+89.2%+1,104.7%$170.30M$40K0.0050Earnings ReportTLSITriSalus Life Sciences3.0711 of 5 stars$4.52-7.1%$10.75+138.1%-10.1%$169.18M$29.43M-3.79106ELMDElectromed2.0734 of 5 stars$19.72+0.2%$33.50+69.9%+27.5%$165.37M$61.44M26.29160Positive NewsLNSRLENSAR0.6926 of 5 stars$12.71-0.3%$15.00+18.0%+173.3%$152.10M$53.49M-3.03110MBOTMicrobot Medical1.5758 of 5 stars$3.22+4.4%$9.00+179.9%+281.4%$148.08MN/A-5.6120Trending NewsAnalyst DowngradeOptions VolumeAnalyst RevisionPDEXPro-Dex1.7585 of 5 stars$44.79+1.6%$56.00+25.0%+119.7%$145.46M$64.12M15.93140LAKELakeland Industries3.942 of 5 stars$15.04-0.2%$26.00+72.9%-37.3%$142.98M$167.21M-5.002,100AVRAnteris Technologies GlobalN/A$3.79-0.3%$16.50+335.4%N/A$136.67M$2.70M0.00138 Related Companies and Tools Related Companies Monogram Orthopaedics Competitors CapsoVision Competitors Biosig Technologies Competitors TriSalus Life Sciences Competitors Electromed Competitors LENSAR Competitors Microbot Medical Competitors Pro-Dex Competitors Lakeland Industries Competitors Anteris Technologies Global Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:APT) was last updated on 8/25/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Pro Tech, Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Pro Tech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access